Effectiveness of PFO Closure in Preventing Cerebrovascular Events: A 13‐Year Retrospective Cohort Study
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70051 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Pardis Javadian und 13 weiteren Autor:innen. Beteiligte Einrichtung: Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Foramen Ovale, Patent, Cardiac Catheterization, Stroke. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Background
The association between patent foramen ovale (PFO) and cerebrovascular events and major adverse cardiovascular events (MACE) is less explored.
Aims
This study evaluates the effectiveness of PFO closure versus non‐closure on the risk of MACE and cerebrovascular events in patients with or without a CVA history.
Methods
This retrospective cohort study included patients diagnosed with PFO who were younger than 60 years old and referred to the Professor Kojuri Cardiovascular Clinic between 2010 and 2023. Patients were interviewed for the occurrence of MACEs post‐diagnosis or closure. The MACE components consisted of myocardial infarction (MI), cerebrovascular accidents or transient ischemic attacks (CVA/TIA), decompensated heart failure (DHF), and cardiac death.
Results
Among 122 participants with prior CVA, MACE incidence was seen at 13 (10.6%), including eight new CVAs (6.6%), three new MI events (2.5%), and two new cases of acute DHF (1.6%). No significant differences in MACE incidence rates were found between PFO closure and non‐closure groups ( p = 0.430), nor in new CVA occurrences ( p = 0.479). Among 58 patients without prior CVA, MACE incidence was five (8.6%), including two new MIs (3.4%), two new cases of acute DHF (3.4%), and one new CVA (1.7%). Similarly, no significant differences were observed in MACE rates ( p = 0.192) or new CVA occurrences ( p = 0.328) between closed and non‐closed groups.
Conclusion
Our findings over a period of 13 years suggest that PFO closure may not provide a clear protective benefit against MACEs in this population, regardless of prior CVA history, highlighting the need for further research to identify specific patient subgroups that might benefit from this intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shiraz University of Medical Sciences, Shiraz, Iran.
- Professor Kojuri Cardiology Clinic, Niayesh Medical Complex, Shiraz, Iran.
- Cardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
- Clinical Education Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Reza Golchin Vafa, Javad Kojuri
Zitieren
APA
Javadian, P., Heydarzadeh, R., Vafa, R. G., Zarifkar, H., Hosseini, A. K., Zarifkar, H., Zarifkar, H., Sadeghi, M., Azadian, A., Amiri, F., Mohammadhassani, A., Montaseri, M., Hossein, N., & Kojuri, J. (2025). Effectiveness of PFO Closure in Preventing Cerebrovascular Events: A 13‐Year Retrospective Cohort Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70051
Vancouver
Javadian P, Heydarzadeh R, Vafa RG, Zarifkar H, Hosseini AK, Zarifkar H, et al. Effectiveness of PFO Closure in Preventing Cerebrovascular Events: A 13‐Year Retrospective Cohort Study. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70051
BibTeX
@article{Javadian2025,
author = {Javadian, Pardis and Heydarzadeh, Reza and Vafa, Reza Golchin and Zarifkar, Houyar and Hosseini, Amin Khadem and Zarifkar, Houman and Zarifkar, Hourshad and Sadeghi, Mohammad and Azadian, Alireza and Amiri, Farhang and Mohammadhassani, Ali and Montaseri, Mohammad and Hossein, Nazanin and Kojuri, Javad},
title = {Effectiveness of PFO Closure in Preventing Cerebrovascular Events: A 13‐Year Retrospective Cohort Study},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70051}
}
EUVIMED